BDBM395673 2-{3-[(3R,6R)-6-methyl-1-{[2-(2H-tetrazol-2- yl)phenyl]carbonyl}piperidin-3-yl]-1,2,4- oxadiazol-5-yl}propan-2-ol::US10308645, Example 12

SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)c1noc(n1)C(C)(C)O

InChI Key InChIKey=FNYZXCNSTQAKRI-CHWSQXEVSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 395673   

TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM395673(2-{3-[(3R,6R)-6-methyl-1-{[2-(2H-tetrazol-2- yl)ph...)
Affinity DataIC50:  1.00E+4nMAssay Description:The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM395673(2-{3-[(3R,6R)-6-methyl-1-{[2-(2H-tetrazol-2- yl)ph...)
Affinity DataIC50:  184nMAssay Description:The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent